Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Feb 19, 2004

29777_dirs_2004-02-18_6e1fc85f-4840-4c29-abcf-7066522f7e47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-02-17

Reporting Person: BEGLEY CHRISTOPHER B (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-02-17 Common shares without par value M 29999 $35.36 Acquired 262505 Direct
2004-02-17 Common shares without par value F 26381 $44.31 Disposed 236124 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-02-17 Option (right to buy) $35.36 M 29999 Disposed 2013-02-13 common shares (29999) Direct
2004-02-17 Option (right to buy) $44.31 A 26381 Acquired 2013-02-13 common shares (26381) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 13933 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 13, 2004.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.